Reaction

Thyroid Mass reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 3,746 reports · 106 co-occurring drugs

As of the last recalculation, Thyroid Mass appears in 3,746 FAERS reports alongside 106 co-occurring drug terms. The strongest observed disproportionality signal is METHIMAZOLE (PRR 17.1).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Methimazole	24	17.1	17.1
Liraglutide	109	12.6	12.6
Octreotide Acetate	60	11.0	11.1
Oral Semaglutide	135	10.6	10.6
Asfotase Alfa	16	8.9	8.9
Niraparib	33	8.3	8.3
Dulaglutide	117	7.5	7.5
Ciclesonide	17	7.0	7.0
Ocrelizumab	72	6.6	6.6
Cladribine	11	6.4	6.4
Thyroid, Porcine	12	6.3	6.3
Hyoscyamine Sulfate	10	6.1	6.1
Avapritinib	13	6.0	6.0
Ribociclib	33	5.9	5.9
Alemtuzumab	20	5.8	5.8
Human Immunoglobulin G	20	5.4	5.4
Clobetasol Propionate Ointment Usp, 0.05%	10	5.4	5.4
Clobetasol Propionate	10	5.4	5.4
Levothyroxine Sodium	283	5.3	5.3
Infliximab-Dyyb	26	5.0	5.0
Amiodarone Hydrochloride	10	5.0	5.0
Tolterodine Tartrate	8	5.0	5.0
Cyclobenzaprine Hydrochloride	8	5.0	5.0
Methocarbamol	20	4.9	4.9
Cetirizine Hcl	8	4.9	4.9
Sucralfate Oral	12	4.7	4.7
Sucralfate Oral Suspension	12	4.7	4.7
Anastrozole Tablets	18	4.7	4.7
Tizanidine Hydrochloride	15	4.6	4.6
Cyclobenzaprine	41	4.6	4.6
Biotin	25	4.5	4.5
Tirzepatide	124	4.4	4.4
Letrozole	48	4.4	4.4
Methocarbamol Tablets	13	4.3	4.3
Oxycodone And Acetaminophen Tablets	9	4.2	4.2
Paroxetine Hydrochloride Hemihydrate	25	4.2	4.2
Mupirocin	10	4.1	4.1
Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, And Amphetamine Sulfate	26	4.1	4.1
Paroxetine	25	4.1	4.1
Naproxen Sodium, Dextromethorphan Hydrobromide, Guaifenesin	15	4.1	4.1
Naproxen Sodium, Pseudoephedrine Hydrochloride	15	4.1	4.1
Fulvestrant	24	4.1	4.1
Mupirocin Calcium	10	4.1	4.1
Buspirone Hydrochloride	8	4.0	4.0
Tiotropium Bromide Inhalation Spray	8	4.0	4.0
Anastrozole	26	4.0	4.0
Baclofen	60	3.9	3.9
Oxazepam	15	3.9	3.9
Calcium, Magnesium, Potassium, And Sodium Oxybates	6	3.9	3.9
Rizatriptan Benzoate	7	3.8	3.8
Oxybutynin Chloride	6	3.8	3.8
Insulin Degludec	16	3.8	3.8
Goserelin	9	3.7	3.7
Dolutegravir Sodium	6	3.7	3.7
Ropinirole	10	3.6	3.6
Adalimumab	416	3.6	3.6
Lanreotide Acetate	5	3.5	3.5
Tizanidine	15	3.5	3.5
Dextroamphetamine Sulfate, Dextroamphetamine Saccharate, Amphetamine Sulfate And Amphetamine Aspartate	26	3.5	3.5
Selexipag	16	3.5	3.5
Armodafinil	13	3.4	3.4
Loratadine Tablet	32	3.3	3.3
Sodium Oxybate	39	3.3	3.3
Losartan	102	3.3	3.3
Modafinil	19	3.3	3.3
Instalax Polyethylene Glycol 3350	7	3.1	3.1
Letrozole Tablets	26	3.0	3.0
Fremanezumab-Vfrm	6	2.9	2.9
Risankizumab-Rzaa	42	2.9	2.9
Fingolimod Hcl	43	2.8	2.8
Pegvaliase-Pqpz	4	2.7	2.7
Budesonide, Glycopyrrolate, And Formoterol Fumarate	5	2.7	2.7
Denosumab	93	2.6	2.6
Fexofenadine Hydrochloride	10	2.6	2.6
Linaclotide	12	2.5	2.5
Omalizumab	38	2.5	2.5
Dapagliflozin	14	2.5	2.5
Palbociclib	40	2.3	2.3
Diroximel Fumarate	5	2.3	2.3
Umeclidinium Bromide And Vilanterol Trifenatate	7	2.3	2.3
Interferon Beta-1A	78	2.3	2.3
Vedolizumab	35	2.3	2.3
Upadacitinib	33	2.3	2.3
Riociguat	13	2.2	2.2
Teriflunomide	18	2.2	2.2
Mometasone Furoate And Formoterol Fumarate Dihydrate	6	2.1	2.1
Ranolazine	4	2.1	2.1
Belimumab	12	2.1	2.1
Vibegron	3	2.1	2.1
Inclisiran	3	2.1	2.1
Secukinumab	59	2.0	2.0
Dalfampridine	26	2.0	2.0
Durvalumab	7	1.9	1.9
Acalabrutinib	4	1.8	1.8
Dimethyl Fumarate	39	1.8	1.8
Peginterferon Beta-1A	4	1.7	1.7
Romosozumab-Aqqg	4	1.6	1.6
Exenatide	15	1.6	1.6
Glatiramer Acetate	17	1.6	1.6
Sarilumab	7	1.5	1.5
Sacubitril And Valsartan	26	1.2	1.2
Tapentadol Hydrochloride	6	1.0	1.0
Apremilast	19	0.7	0.7
Evolocumab	21	0.7	0.7
Cinacalcet Hydrochloride	6	0.7	0.7
Valbenazine	3	0.7	0.7

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.